These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 7543585

  • 21. Naturally occurring point mutation in the C terminus of the polymerase gene prevents duck hepatitis B virus RNA packaging.
    Chen Y, Robinson WS, Marion PL.
    J Virol; 1992 Feb; 66(2):1282-7. PubMed ID: 1309904
    [Abstract] [Full Text] [Related]

  • 22. Establishment and assessment of two methods for quantitative detection of serum duck hepatitis B virus DNA.
    Chen YX, Huang AL, Qi ZY, Guo SH.
    World J Gastroenterol; 2004 Sep 15; 10(18):2666-9. PubMed ID: 15309716
    [Abstract] [Full Text] [Related]

  • 23. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
    Tomita T, Yokosuka O, Tagawa M, Saisho H, Tamura S, Fukuda I, Omata M.
    J Hepatol; 2000 May 15; 32(5):850-8. PubMed ID: 10845674
    [Abstract] [Full Text] [Related]

  • 24. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
    Zoulim F, Dannaoui E, Borel C, Hantz O, Lin TS, Liu SH, Trépo C, Cheng YC.
    Antimicrob Agents Chemother; 1996 Feb 15; 40(2):448-53. PubMed ID: 8834896
    [Abstract] [Full Text] [Related]

  • 25. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
    Tsiquaye KN, Slomka MJ, Maung M.
    J Med Virol; 1994 Mar 15; 42(3):306-10. PubMed ID: 8006644
    [Abstract] [Full Text] [Related]

  • 26. A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus.
    Addison WR, Wong WW, Fischer KP, Tyrrell DL.
    Antiviral Res; 2000 Oct 15; 48(1):27-37. PubMed ID: 11080538
    [Abstract] [Full Text] [Related]

  • 27. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
    Fourel I, Cullen JM, Saputelli J, Aldrich CE, Schaffer P, Averett DR, Pugh J, Mason WS.
    J Virol; 1994 Dec 15; 68(12):8321-30. PubMed ID: 7966625
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion.
    Yang W, Summers J.
    J Virol; 1998 Nov 15; 72(11):8710-7. PubMed ID: 9765413
    [Abstract] [Full Text] [Related]

  • 30. Characterisation of the Indian strain of duck hepatitis B virus (DHBV) and development of a carrier duck colony for antiviral drug testing.
    Munshi A, Mehrotra R, Panda SK.
    Trop Gastroenterol; 1994 Nov 15; 15(2):77-85. PubMed ID: 7831721
    [Abstract] [Full Text] [Related]

  • 31. Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms.
    Bhat P, Snooks MJ, Anderson DA.
    J Virol; 2011 Dec 15; 85(23):12474-81. PubMed ID: 21937643
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular characterization of duck hepatitis B virus isolated from Hubei brown ducks.
    Hu Q, Zhang X, Lei Y, Zhang Z, Mengji L, Yang D.
    J Huazhong Univ Sci Technolog Med Sci; 2006 Dec 15; 26(5):633-6. PubMed ID: 17219989
    [Abstract] [Full Text] [Related]

  • 34. Duck hepatitis B virus replication in primary bile duct epithelial cells.
    Lee JY, Culvenor JG, Angus P, Smallwood R, Nicoll A, Locarnini S.
    J Virol; 2001 Aug 15; 75(16):7651-61. PubMed ID: 11462037
    [Abstract] [Full Text] [Related]

  • 35. Simple and visible detection of duck hepatitis B virus in ducks and geese using loop-mediated isothermal amplification.
    Ji J, Xu X, Wu Q, Wang X, Li W, Yao L, Kan Y, Yuan L, Bi Y, Xie Q.
    Poult Sci; 2020 Feb 15; 99(2):791-796. PubMed ID: 32029161
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Chemical disinfection of duck hepatitis B virus: a model for inactivation of infectivity of hepatitis B virus.
    Tsiquaye KN, Barnard J.
    J Antimicrob Chemother; 1993 Aug 15; 32(2):313-23. PubMed ID: 8226434
    [Abstract] [Full Text] [Related]

  • 38. A duck hepatitis B virus strain with a knockout mutation in the putative X ORF shows similar infectivity and in vivo growth characteristics to wild-type virus.
    Meier P, Scougall CA, Will H, Burrell CJ, Jilbert AR.
    Virology; 2003 Dec 20; 317(2):291-8. PubMed ID: 14698667
    [Abstract] [Full Text] [Related]

  • 39. Gene expression and active virus replication in the liver after injection of duck hepatitis B virus DNA into the peripheral vein of ducklings.
    Tagawa M, Yokosuka O, Imazeki F, Ohto M, Omata M.
    J Hepatol; 1996 Mar 20; 24(3):328-34. PubMed ID: 8778201
    [Abstract] [Full Text] [Related]

  • 40. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.
    Seifer M, Hamatake RK, Colonno RJ, Standring DN.
    Antimicrob Agents Chemother; 1998 Dec 20; 42(12):3200-8. PubMed ID: 9835515
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.